As of Q4'25, RKLB's latest operating expenses show R&D Expenses at USD 78.8M and SG&A Expenses at USD 40.5M. This marks the highest quarterly figures for both categories within the period covered, reflecting continued growth in overall operating outlays. From Q1'23 to Q4'25, both R&D and SG&A Expenses exhibit a clear upward trend, with R&D Expenses rising sharply from USD 23.9M to USD 78.8M and SG&A Expenses increasing from USD 28.5M to USD 40.5M. The most significant acceleration in R&D spending occurs after Q2'24, while SG&A Expenses show a more moderate but steady increase, with a notable spike in Q4'24 and Q3'25. Overall, the data indicates escalating investment in research and development, outpacing growth in SG&A, and suggests a strategic focus on innovation and expansion over the observed quarters.